(Q51103688)

29 March 2018

title

Lifestyle modification in the pharmacologic treatment of obesity: a pilot investigation of a potential primary care approach. (English)

1 reference

29 March 2018

0 references

1 reference

Wadden TA

1

1 reference

29 March 2018

Berkowitz RI

2

1 reference

29 March 2018

Vogt RA

3

1 reference

29 March 2018

Steen SN

4

1 reference

29 March 2018

Stunkard AJ

5

1 reference

29 March 2018

Foster GD

6

1 reference

29 March 2018

publication date

1 May 1997

1 reference

29 March 2018

published in

Obesity

1 reference

29 March 2018

volume

5

1 reference

29 March 2018

issue

3

1 reference

29 March 2018

page(s)

218-226

1 reference

29 March 2018

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1997.TB00296.X

Combined drug treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1997.TB00296.X

Effect of degree of weight loss on health benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1997.TB00296.X

Use and abuse of appetite-suppressant drugs in the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1997.TB00296.X

Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1997.TB00296.X

International trial of long-term dexfenfluramine in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1997.TB00296.X

Anorectic agents lower a body weight set point

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1997.TB00296.X

Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1997.TB00296.X

Long-term weight control study. VII (weeks 0 to 210). Serum lipid changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1997.TB00296.X

Long-term weight control study. III (weeks 104 to 156). An open-label study of dose adjustment of fenfluramine and phentermine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1997.TB00296.X

Beta-agonists as antiobesity, antidiabetic and nutrient partitioning agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1550-8528.1997.TB00296.X

10.1002/J.1550-8528.1997.TB00296.X

21 January 2018

Identifiers

DOI

1 reference

29 March 2018

PubMed ID

9192396

1 reference

29 March 2018